Le Lézard
Classified in: Health, Science and technology
Subject: MAT

Pregnantish Survey Reveals Why Millennials Leave Fertility Clinics


NEW YORK, Sept. 21, 2020 /PRNewswire-PRWeb/ -- In an era when more and more top-tier employers offer fertility benefits such as egg freezing and IVF, a new survey by pregnantish, the fertility community and content site, reveals today the top six reasons patients decide to stay with or change fertility doctors.

Based on responses from more than 1,000 fertility patients who swiftly completed the survey without any incentive but getting their feedback to healthcare providers, the study underscores the importance of relationship-building in ensuring they do not give up on practitioner-led fertility assistance.

The median age of the confidential survey's respondents was 33, with an average of four years of trying to conceive.

"This report reflects the changing face of infertility," says pregnantish Founder and author Andrea Syrtash. "It's important to ensure that providers understand what motivates patients so they do not give up on the process or practitioner-led fertility assistance."

According to a recent Society for Reproductive Endocrinology and Infertility Workforce Survey, nearly 1,300 reproductive endocrinologists currently practice in the U.S., while every year, more than 75,000 babies are born with the help of Assisted Reproductive Technology (ART) ?a number that has doubled since 2007, according to the Centers for Disease Control.

"As the number of patients and providers grow, so too does the need for open communication," says Syrtash, a noted relationship expert and author of numerous books, including Cheat on Your Husband and He's Just Not Your Type (and That's a Good Thing). "Increasingly, today's fertility patient is a Millennial who wants a much more active and self-directed role in her treatment and is seeking a supportive connection with her doctor and practice. Today's patient is more of an advocate than ever before," she says.

"Every fertility patient wants to feel seen and heard ? and every practitioner wants a thriving practice, but both sides experience extreme time and communication challenges," adds Syrtash. "We found that while few patients want to change doctors, patients will make the leap if they don't feel that the relationship is working."

"(I left because) I did not feel a connection to the clinic. It felt like I was just another patient and when you spend this much money, you need to feel important." ? Ranzie, 28, trying to conceive for 18 months

"I value a doctor who says this isn't OK. This shouldn't be happening. That validation is important." ? Samantha, 28, trying to conceive for three and a half years

KEY FINDINGS

Real Talk About Why I Left My Fertility Doctor finds that the top reasons patients leave their doctor include:

By contrast, the top four reasons patients choose to stay with their fertility practice are:

And what patients value most in their fertility doctor include:

Using these findings and in consultation with an Advisory Panel of experts, pregnantish has developed relationship guidelines for healthcare providers to help optimize communication with patients in the time they already spend together. These guidelines and the free Real Talk Series Workshop and Tools, were made possible by third-party Co-Sponsors EMD Serono and CooperSurgical Fertility and Genomic Solutions. Both were based on the "Real Talk Four E's Protocol," which encourages all healthcare provider team members to empathize, encourage, educate and empower patients, walking them through common scenarios and patient frustrations that can prevent optimal outcomes. Healthcare providers who take the time to complete a workshop and learn key tools to help foster strong patient-provider relationships will be recognized on the Pregnantish Verified Network. Learn more at pregnantishverified.com.

"In the end, it's about helping to strengthen the patient-provider relationship so patients don't leave treatment prematurely," says Syrtash, "and so it's a win for all who have the shared goal of creating healthy babies and happy families."

Pregnantish Relationship Guidelines and Real Talk Series Workshop were written in consultation with Pregnantish Advisory Panel members Dr. Serena H. Chen; Dr. Aimee D. Eyvazzadeh, MPH; Dr. Eric J. Forman, HCLD; Dr. Jason Griffith; and Dr. Julie Lamb and the help of data scientists. The study is based on a confidential survey of 1,060 patients, conducted February to April 2019.

About Pregnantish Inc.
Pregnantish, a healthcare media company, launched in early 2017 to elevate the conversation about the process of getting pregnant with the help of reproductive science and technology. Today, a diverse cross-section of readers come to pregnantish first to find the content, support and events they need to travel their own fertility journey.
Pregnantish is now home to the Pregnantish Verified Network, featuring fertility healthcare providers and other partners committed to improving the patient-provider relationship through the pregnantish "Real Talk Series Workshop" To learn more, visit pregnantishverified.com.

 

SOURCE Pregnantish


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
ICEYE, a global leader in satellite-powered disaster management solutions, has announced a new data collaboration with Juniper Re, LLC ("Juniper Re"), the dynamic reinsurance broking arm and indirect subsidiary of BRP Group, Inc. . Juniper Re will...

at 02:00
CACI is delighted to announce that its Cygnum software will be used by the Environment Agency as a logistics planning tool to schedule its workforce and assets in the preparation of and response to incidents across England ranging from small...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:38
The Barcelona R&D Center ("the Center") of Wanhua Chemical (SHA:600309; "the Company"), located at Cornella de Llobregat, has officially opened its doors as a pivotal move by the company to advance its footprint in Europe and beyond with a quicker...



News published on and distributed by: